Back to DE D. E. Shaw & Co., Inc.
XGN3 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in EXAGEN INC
Yes. D. E. Shaw holds 49,712 shares of XGN (Exagen), worth $231,161, as of its Q2 2026 13F filing. It increased the position by 15,143 shares (+43.8%) from Q1 2026. D. E. Shaw has held XGN since Q4 2025, across 3 quarterly 13F filings.
Current Value
$231,161
Current Shares
49,712
Total Value Change
+$39,161
Total Shares Change
+18,133
Quarter-by-Quarter History
Other major holders of XGN: WASATCH ADVISORS LP, RTW INVESTMENTS, LP